Comparison of the Photodynamic Effect of Exogenous Photoprotoporphyrin and Protoporphyrin IX on PAM 212 Murine Keratinocytes¶
- 1 January 2002
- journal article
- research article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 76 (5) , 530-7
- https://doi.org/10.1562/0031-8655(2002)076<0530:cotpeo>2.0.co;2
Abstract
A comparative study of the cellular photosensitizing properties of protoporphyrin IX (PpIX) and photoprotoporphyrin (Ppp) was carried out in the transformed murine keratinocyte cell line, PAM 212. Time-course fluorescence studies were performed to determine the rate of uptake by cells together with fluorescence microscopy. The sensitized cells were laser irradiated with a range of light doses at 635 or 670 nm to determine the phototoxicity of the two compounds and to investigate their relative fluorescence photobleaching properties. Ppp showed enhanced phototoxicity at both its optimal activation wavelength of 670 nm (eight times more phototoxic than PpIX activated at its optimal wavelength of 635 nm for the same fluence) and at 635 nm (three times more phototoxic than PpIX at the same wavelength), using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. The photobleaching rate of Ppp in cells was found to be higher using 670 nm irradiation compared with that of PpIX at 635 nm irradiation. At 635 nm, however, the photobleaching rate of Ppp was comparable to that of PpIX. The photobleaching quantum yields of the two compounds in cells were found to be similar at approximately 5 x 10(-4), with the same value confirmed at both 670 and 635 nm irradiation for Ppp. The fluorescence lifetime of Ppp in cells was measured as 5.4 ns using time-correlated single photon counting.Keywords
This publication has 31 references indexed in Scilit:
- Photodynamic therapy: a clinical reality in the treatment of cancerThe Lancet Oncology, 2000
- Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acidGastroenterology, 1998
- 5-Aminolevulinic acid-based photodynamic therapyCancer, 1997
- Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.Gut, 1995
- Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancerBritish Journal of Cancer, 1994
- Photodynamic Therapy in Gastroenterology - Current Status and Future ProspectsEndoscopy, 1993
- Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid: An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?Journal of the American Academy of Dermatology, 1993
- New trends in photobiologyJournal of Photochemistry and Photobiology B: Biology, 1992
- Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour modelBritish Journal of Cancer, 1992
- Photodynamic therapy with endogenous protoporphyrinJournal of Photochemistry and Photobiology B: Biology, 1990